EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

IDO1, IL4I1: Novel Immune Checkpoints in Breast Cancer Tumor-Associated Macrophages

Aorong Shi, Yanrong An, Fen Yun, Xia Liu, Yongfeng Jia

Breast Cancer: Targets and Therapy · 2025-12 · Volume 17 · 1279-1292

DOI: 10.2147/bctt.s563049 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Breast Cancer: Targets and Therapy, 2025-12. Verfasst von Aorong Shi und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medicine, Inner Mongolia Medical University, Hohhot, 010059, People's Republic of China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

IDO1IL4I1breast cancerimmune cell infiltrationmetabolic reprogrammingtumor microenvironment

Autor:innen und Institutionen

  • School of Basic Medicine, Inner Mongolia Medical University, Hohhot, 010059, People's Republic of China.
  • Department of Pathology, Affiliated Hospital of Inner Mongolia Medical University, Hohhot, 010030, People's Republic of China.

Zitieren

APA

Shi, A., An, Y., Yun, F., Liu, X., & Jia, Y. (2025). IDO1, IL4I1: Novel Immune Checkpoints in Breast Cancer Tumor-Associated Macrophages. Breast Cancer: Targets and Therapy, Volume 17, 1279-1292. https://doi.org/10.2147/bctt.s563049

Vancouver

Shi A, An Y, Yun F, Liu X, Jia Y. IDO1, IL4I1: Novel Immune Checkpoints in Breast Cancer Tumor-Associated Macrophages. Breast Cancer: Targets and Therapy. 2025;Volume 17:1279-1292. doi:10.2147/bctt.s563049

BibTeX
@article{Shi2025,
  author = {Shi, Aorong and An, Yanrong and Yun, Fen and Liu, Xia and Jia, Yongfeng},
  title = {IDO1, IL4I1: Novel Immune Checkpoints in Breast Cancer Tumor-Associated Macrophages},
  journal = {Breast Cancer: Targets and Therapy},
  year = {2025},
  volume = {Volume 17},
  pages = {1279--1292},
  doi = {10.2147/bctt.s563049}
}
Kostenlos starten →